Aptorum Group Merges with DiamiR Biosciences
Ticker: APM · Form: 6-K · Filed: Sep 10, 2025 · CIK: 1734005
| Field | Detail |
|---|---|
| Company | Aptorum Group Ltd (APM) |
| Form Type | 6-K |
| Filed Date | Sep 10, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: merger, acquisition, biotech
Related Tickers: APM
TL;DR
APM is merging with DiamiR Biosciences, deal inked July 14th, announced Sept 10th.
AI Summary
Aptorum Group Ltd. announced on September 10, 2025, that it entered into an Agreement and Plan of Merger on July 14, 2025, with DiamiR Biosciences Corp. This merger involves Aptorum forming a wholly owned subsidiary, Merger Sub, which will merge with DiamiR.
Why It Matters
This merger signifies a strategic move by Aptorum Group to expand its operations and potentially integrate new technologies or market access through the acquisition of DiamiR Biosciences.
Risk Assessment
Risk Level: medium — Mergers and acquisitions inherently carry risks related to integration, regulatory approval, and market reception.
Key Players & Entities
- Aptorum Group Ltd (company) — Filer of the report and party to the merger agreement.
- DiamiR Biosciences Corp (company) — Party to the merger agreement.
- July 14, 2025 (date) — Date the Agreement and Plan of Merger was entered into.
- September 10, 2025 (date) — Date the report was filed.
- Merger Sub (company) — Wholly owned subsidiary of Aptorum Group to be formed for the merger.
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K filing is to report on the Agreement and Plan of Merger entered into by Aptorum Group Limited and DiamiR Biosciences Corp.
When was the merger agreement between Aptorum Group and DiamiR Biosciences signed?
The Agreement and Plan of Merger was entered into on July 14, 2025.
What is the role of 'Merger Sub' in this transaction?
Merger Sub is a direct, wholly owned subsidiary that Aptorum Group will form in Delaware to merge with DiamiR Biosciences.
Which company is the foreign private issuer filing this report?
Aptorum Group Limited, a Cayman Islands exempted company, is the foreign private issuer filing this report.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of September 10, 2025.
Filing Stats: 259 words · 1 min read · ~1 pages · Grade level 16.2 · Accepted 2025-09-10 08:30:23
Filing Documents
- ea0256533-6k_aptorum.htm (6-K) — 9KB
- ea025653301ex99-1_aptorum.htm (EX-99.1) — 22KB
- ex99-1_001.jpg (GRAPHIC) — 396KB
- ex99-1_002.jpg (GRAPHIC) — 1122KB
- ex99-1_003.jpg (GRAPHIC) — 529KB
- ex99-1_004.jpg (GRAPHIC) — 798KB
- ex99-1_005.jpg (GRAPHIC) — 503KB
- ex99-1_006.jpg (GRAPHIC) — 579KB
- ex99-1_007.jpg (GRAPHIC) — 499KB
- ex99-1_008.jpg (GRAPHIC) — 519KB
- ex99-1_009.jpg (GRAPHIC) — 765KB
- ex99-1_010.jpg (GRAPHIC) — 559KB
- ex99-1_011.jpg (GRAPHIC) — 602KB
- ex99-1_012.jpg (GRAPHIC) — 631KB
- ex99-1_013.jpg (GRAPHIC) — 692KB
- ex99-1_014.jpg (GRAPHIC) — 623KB
- ex99-1_015.jpg (GRAPHIC) — 755KB
- ex99-1_016.jpg (GRAPHIC) — 274KB
- 0001213900-25-086383.txt ( ) — 13593KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Aptorum Group Limited Date: September 9, 2025 By: /s/ Ian Huen Name: Ian Huen Title: CEO 2